Oncology

Key takeaways

• The review included 52 publications addressing precision-oncology nursing roles, competencies, or education.
• Nursing contributions extended from genomic risk assessment and communication to navigation, service integration, and governance.
• Most identified education emphasized foundational capabilities, with less explicit preparation for advanced interpretive and leadership roles.
• The proposed three-level competency model is a framework and has not been validated as an education or patient-outcome intervention.

Nursing implications

• Clarify which genomic conversations, assessments, and coordination tasks fall within the nurse's verified competency and local role. Use approved patient resources, route interpretive questions to qualified genetics or oncology clinicians, and document education and follow-up needs.

Limitations & cautions

• This was a scoping review that mapped a heterogeneous literature and education landscape rather than evaluating effectiveness. The education search included generative-AI-assisted grey-literature methods, identified program availability may change, and the proposed competency levels require validation before they are used for credentialing or scope decisions.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The real-world cohort included 303 patients treated at 18 oncology centers, with 76 patients age 65 or older.
• Response, disease control, treatment modifications, and grade 3 or higher neutropenia were comparable between age groups.
• Chronological age was not independently associated with overall or progression-free survival after adjustment.
• The selected older group and retrospective design limit conclusions about frailer adults or causal treatment effects.

Nursing implications

• Review ordered blood counts and current symptoms before treatment, assess how comorbidities and functional status affect the care plan, and escalate fever, infection concerns, or suspected treatment toxicity promptly. Communicate trends and treatment interruptions so the oncology team can make patient-specific dosing and supportive-care decisions.

Limitations & cautions

• This was a retrospective study of a selected treated population across Central European centers, and only 76 patients were age 65 or older. Age 65 does not capture frailty, selection into treatment may explain apparent similarities, and residual confounding remains. The abstract reports severe neutropenia but does not provide a complete age-stratified adverse-event profile.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The single-center randomized trial enrolled 210 adults aged 65 or older receiving chemotherapy for non-Hodgkin lymphoma.
• Fall incidence among 194 follow-up completers was 7.1% with the preventive nursing program and 19.8% with standard care.
• The intervention group also had better functional-mobility, chemotherapy-completion, and quality-of-life outcomes.
• The 12-week, single-center design and completer analysis limit generalizability.

Nursing implications

• Use the facility's oncology fall-risk process to reassess mobility and treatment-related risks across chemotherapy visits, then individualize prevention measures and document changes. Escalate new weakness, neuropathy, dizziness, falls, or injuries through the oncology team rather than adopting the study protocol without local review.

Limitations & cautions

• The trial was conducted at one center, followed patients for 12 weeks, and reports results for 194 of 210 enrolled participants who completed follow-up. The abstract does not describe allocation concealment, blinding, or every component of the intervention, and the authors call for multicenter, longer-term validation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis included 54 randomized trials and 10,455 adults receiving chemotherapy.
• Olanzapine-containing regimens improved multiple nausea and vomiting outcomes versus placebo-containing regimens.
• Direct comparisons did not show significant efficacy differences between 10 mg and 5 mg.
• Dose reduction to 5 mg did not clearly reduce sedation, and evidence for 2.5 mg was very limited.

Nursing implications

• Assess both breakthrough nausea or vomiting and sedation when olanzapine is part of an ordered antiemetic regimen. Do not interpret a lower dose as sedation-free, and communicate symptom-control or tolerability concerns to the oncology team rather than changing prophylaxis independently.

Limitations & cautions

• Network estimates combine direct and indirect comparisons across different chemotherapy regimens, emetogenic-risk groups, and antiemetic backbones. The abstract does not report certainty ratings for each comparison. Evidence for 2.5 mg was sparse, and dose reduction from 10 mg to 5 mg did not clearly reduce sedation.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The trial randomized 51 women newly diagnosed with breast cancer, and 44 completed follow-up.
• The intervention added six weekly Roy-model nursing sessions to standard psycho-oncology care.
• Psychosocial adjustment improved more in the intervention group over time.
• Resilience also improved, with outcomes followed for three months.

Nursing implications

• Oncology services may consider a structured, theory-guided nursing pathway for early adjustment support while preserving standard psycho-oncology care. The study does not establish one universal session format or demonstrate effects on treatment adherence, symptoms, or longer-term outcomes.

Limitations & cautions

• This was a single-center trial with 51 randomized participants and a per-protocol analysis of 44 completers. Outcomes were self-reported, follow-up lasted three months, and the results do not establish effects on cancer treatment, physical symptoms, adherence, or longer-term mental health.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The six-clinic trial randomized 1,214 adults with advanced solid cancer to digital symptom monitoring plus usual care or usual care alone.
• The intervention combined weekly symptom reports, automated self-management guidance, and nurse follow-up for severe alerts.
• Quality of life and self-efficacy were better maintained over 18 weeks with digital monitoring.
• Fewer analyzed participants had worsening unplanned hospitalization episodes, and mean inpatient days were lower, while emergency-department use was not significantly different.

Nursing implications

• For oncology services considering remote monitoring, the intervention should be understood as weekly reporting plus automated guidance plus a staffed nurse-response workflow. The results do not show that passive symptom collection alone is effective, and they should not be generalized beyond the studied advanced-cancer population without local evaluation.

Limitations & cautions

• The trial was conducted in six Hong Kong palliative clinics among community-dwelling adults with advanced solid cancer who were no longer receiving systemic therapy. Follow-up was 18 weeks, caregivers used the app for many participants, and hospitalization and performance-status results in the abstract were reported for smaller analyzed groups than the 1,214 people randomized.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• At 3 to 4 weeks, more intervention patients were free of both diarrhea and constipation than usual-care patients (53.8% vs 27.5%, p=0.01).
• Freedom from constipation alone was also higher in the intervention group (74.4% vs 45%, p=0.01).
• The program was highly feasible (94.1% recruitment, 98.8% completion) and acceptable (over 80% adopted self-management strategies).
• Gains were sustained at 12 weeks within a sub-sample, and the authors call for a fully powered randomized controlled trial.

Nursing implications

• For oncology nurses, the findings suggest that a structured, nurse-led program of dietary education, self-management coaching, and regular telephone follow-up can help chemotherapy patients manage diarrhea and constipation and is well accepted by patients. Because this was a small pilot, any such program should be pursued through the treating team rather than adopted as established practice.

Limitations & cautions

• This was a single-country pilot randomized trial designed to test feasibility rather than to prove effectiveness, so the sample was small and the 12-week outcomes came from a sub-sample of intervention participants only. The culturally tailored, low-resource design may not transfer directly to other settings, and the authors state that a fully powered randomized controlled trial is still needed.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• Honey combined with cryotherapy delayed the onset of radiation-induced oral mucositis (15.58 vs 11.58 days; P = 0.003).
• The incidence of grade II or higher mucositis was lower with the intervention (11.11% vs 33.33%; P = 0.045).
• Severity grading favored the intervention group in both the second week (P = 0.005) and third week (P = 0.014) of treatment.
• The study was small (72 patients, 36 per group) and single-center, and the authors call for further validation.

Nursing implications

• For oncology nurses caring for head and neck cancer patients on chemoradiotherapy, the findings suggest that a structured honey and cryotherapy routine around radiotherapy sessions may postpone and soften oral mucositis, improving comfort and treatment tolerance. Any such protocol should be adopted through the treating team rather than improvised, given the small single-center evidence base.

Limitations & cautions

• This was a single-center prospective study of only 72 patients conducted between July 2021 and May 2022, so the results may not generalize and could reflect local practice. The authors describe the benefit as probable and explicitly call for more comprehensive studies before honey plus cryotherapy is treated as established practice.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• ONS and ASCO jointly published a guideline on managing antineoplastic extravasation, built with GRADE methodology and a systematic review.
• Recommendations address antidote use for vesicants and for irritants with vesicant properties.
• They also address thermal compress application and how long to apply it.
• They call for early surgical referral or specialty escalation for extravasation involving a central venous access device.

Nursing implications

• Know where your unit's extravasation protocol and antidote kit live before a leak happens, and confirm they reflect current ONS/ASCO guidance. Determine whether a leaked agent is a vesicant or an irritant with vesicant properties, apply the correct thermal compress for the recommended duration, and escalate a central venous access device extravasation early rather than waiting.

Limitations & cautions

• As a consensus practice guideline, the strength of individual recommendations depends on evidence that is often limited for a rare event. The abstract names recommendation topics but not specific agents, temperatures, or durations, so the full text must be read before applying any intervention.
• AI-summarized from the linked source. Review the original article before applying to practice.

Key takeaways

• The network meta-analysis pooled 49 trials, 24 methods, and 3,887 patients.
• Massage therapy ranked highest for reducing cancer-related fatigue.
• Strengthening exercise ranked lowest in this particular analysis.
• The authors call for larger, higher-quality trials before adopting one approach as best.

Nursing implications

• Assess cancer-related fatigue routinely as a symptom rather than treating it as unavoidable, offer low-risk comfort measures such as massage where appropriate and consistent with the care plan, and avoid presenting any one therapy as proven best given the wide uncertainty.

Limitations & cautions

• Few trials supported each individual therapy, and much of the evidence base used culturally specific modalities, limiting generalizability. The rankings signal promise, not certainty, and do not establish a single recommended program.
• AI-summarized from the linked source. Review the original article before applying to practice.